Integration of the blandm-1 carbapenemase gene into Proteus genomic island 1 (PGI1-PmPEL) in a Proteus mirabilis clinical isolate

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 1, 2015, Pages 98-102

  Girlich, Delphine ^a   Dortet, Laurent ^a   Poirel, Laurent ^a,b   Nordmann, Patrice ^a,b  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^b University of Fribourg   (Switzerland)

Author keywords

Carbapenem resistance; Genomic island SGI1; NDM 1; P. mirabilis; VEB 6

Indexed keywords

AZTREONAM; BETA LACTAM; CARBAPENEMASE; CEFOXITIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LATAMOXEF; MEROPENEM; NUCLEOTIDE; PENICILLIN DERIVATIVE; RIFAMPICIN; BACTERIAL DNA; BETA LACTAMASE; BETA-LACTAMASE NDM-1;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONING; DNA SEQUENCE; GENE CLUSTER; GENE DELETION; GENE INSERTION SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOMIC ISLAND; HOMOLOGOUS RECOMBINATION; INVERTED REPEAT; NDM 1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEUS GENOMIC ISLAND 1; PROTEUS MIRABILIS; SALMONELLA ENTERICA SEROVAR HEIDELBERG; SALMONELLA GENOMIC ISLAND 1; VEB 6 GENE; CHEMISTRY; CHROMOSOME WALKING; ENZYMOLOGY; GENE ORDER; GENETICS; HUMAN; INTERSPERSED REPEAT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PROTEUS INFECTION;

BETA-LACTAMASES; CHROMOSOME WALKING; DNA, BACTERIAL; GENE ORDER; GENES, BACTERIAL; GENOMIC ISLANDS; HUMANS; INTERSPERSED REPETITIVE SEQUENCES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEUS INFECTIONS; PROTEUS MIRABILIS; SEQUENCE ANALYSIS, DNA;

EID: 84928346616     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku371     Document Type: Article

References (24)

1. Villar HE, Danel F, Livermore DM. Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other β-lactams. J Antimicrob Chemother 1997; 40: 365-70.
2. Pagani L, Migliavacca R, Pallecchi L et al. Emerging extendedspectrum β-lactamases in Proteus mirabilis. J Clin Microbiol 2002; 40: 1549-52.
3. KPC-2 and qnrD in a Chinese hospital. Antimicrob Agents Chemother 2012; 56: 2278-82.
4. Poirel L, Schrenzel J, Cherkaoui A et al. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother 2011; 66: 1730-3.
5. Bonnet R, Marchandin H, Chanal C et al. Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis. Antimicrob Agents Chemother 2002; 46: 2004-6.
6. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int 2014; 2014: 249856.
7. NDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother 2011; 55: 5403-7.
8. Doublet B, Boyd D, Mulvey MR et al. The Salmonella genomic island 1 is an integrative mobilizable element. Mol Microbiol 2005; 55: 1911-24.
9. VEB-6 and qnrA1 in the multiple antibiotic resistance region. J Antimicrob Chemother 2011; 66: 2513-20.
10. Doublet B, Golding GR, Mulvey MR et al. Potential integration sites of the Salmonella genomic island 1 in Proteus mirabilis and other bacteria. J Antimicrob Chemother 2007; 59: 801-3.
11. Bi S, Yan H, Chen M et al. New variant Salmonella genomic island 1-U in Proteus mirabilis clinical and food isolates from South China. J Antimicrob Chemother 2011; 66: 1178-9.
12. Boyd DA, Shi X, Hu QH et al. Salmonella genomic island 1 (SGI1), variant SGI1-I, and new variant SGI1-O in Proteus mirabilis clinical and food isolates from China. Antimicrob Agents Chemother 2008; 52: 340-4.
13. Doublet B, Poirel L, Praud K et al. European clinical isolate of Proteus mirabilis harbouring the Salmonella genomic island 1 variant SGI1-O. J Antimicrob Chemother 2010; 65: 2260-2.
14. Siebor E, Neuwirth C. Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France. J Antimicrob Chemother 2013; 68: 1750-6.
15. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
16. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2012; 18: 1503-7.
17. Nordmann P, Dortet L, Poirel L. Rapid detection of extended-spectrumb-lactamase-producing Enterobacteriaceae. J Clin Microbiol 2012; 50: 3016-22.
18. Dortet L, Nordmann P, Poirel L. Association of the emerging carbapenemase NDM-1 with a bleomycin resistance protein in Enterobacteriaceae and Acinetobacter baumannii. Antimicrob Agents Chemother 2012; 56: 1693-7.
19. RTG-5 in Acinetobacter baumannii. Int J Antimicrob Agents 2012; 40: 257-9.
20. NDM-like genes in Acinetobacter baumannii. Antimicrob Agents Chemother 2012; 56: 1087-9.
21. Bonnin RA, Poirel L, Nordmann P. New Delhi metallo-blactamase-producing Acinetobacter baumannii: a novel paradigm for spreading antibiotic resistance genes. Future Microbiol 2014; 9: 33-41.
22. NDM-1 is a chimera likely constructed in Acinetobacter baumannii. Antimicrob Agents Chemother 2012; 56: 2773-6.
23. Douard G, Praud K, Cloeckaert A et al. The Salmonella genomic island 1 is specifically mobilized in trans by the IncA/C multidrug resistance plasmid family. PLoS One 2010; 5: e15302.
24. Doublet B, Praud K, Bertrand S et al. Novel insertion sequence-and transposon-mediated genetic rearrangements in genomic island SGI1 of Salmonella enterica serovar Kentucky. Antimicrob Agents Chemother 2008; 52: 3745-54.